Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Funding No external funding sources were used for preparation of this manuscript
The recommendations apply to all GLP-1 receptor agonists: semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), liraglutide (Saxenda, Victoza), and orforglipron (Foundayo)
Risks to consider include: hypertension (high blood pressure) maintaining your blood pressure within safe levels dyslipidaemia (high cholesterol) ensuring your cholesterol levels are kept within range Cholesterol management, including being offered statins that lower your cholesterol levels, is considered for people with type 1 diabetes over the age of 40 years, or if you have had type 1 diabetes for longer than 10 years
Boysen NC, Stone MS (2014) Eosinophil-rich granulomatous panniculitis caused by exenatide injection
US$ 23.45
US$ 29.48
US$ 25.05
US$ 29.30
US$ 29.24
US$ 24.74
US$ 20.67
US$ 24.21
